Amneal Pharmaceuticals Balance Sheet (2017-2025) | AMRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	452.10M	4.85M	302.65M	8.95M	6.07M	6.20M	87.33M	25.98M	144.67M	5.30M	86.93M	7.57M	46.52M	5.85M	4.34M	7.90M	6.58M	71.54M	34.73M	28.84M
Cash & Current Investments (Quarter)	452.10M	4.85M	302.65M	8.95M	6.07M	6.20M	87.33M	25.98M	144.67M	5.30M	86.93M	7.57M	46.52M	5.85M	4.34M	7.90M	6.58M	71.54M	34.73M	28.84M
Receivables - Net (Quarter)	530.60M	1,182.84M	627.95M	662.58M	933.58M	688.85M	628.74M	0.00M	545.76M		1.60M	0.95M		1,240.34M	1,213.42M	775.73M	1,282.21M	1,338.54M	1,444.63M	0.41M
Receivables - Other (Quarter)	1.10M	1.30M	1.31M	1.18M	1.59M	100.00M	9.37M	33.13M	14.02M	14.47M	5.12M	2.20M	1.94M	3.45M	7.86M	4.47M	2.44M	3.74M	2.23M	24.20M
Receivables (Quarter)	531.70M	1,184.14M	629.26M	663.76M	935.17M	788.85M	638.10M	33.13M	559.78M	14.47M	6.73M	3.15M	1.94M	1,243.79M	1,221.27M	780.20M	1,284.65M	1,342.27M	1,446.86M	24.61M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	497.01M	523.38M	520.25M	489.39M	512.24M	533.03M	543.86M	530.74M	529.04M	550.56M	576.47M	581.38M	570.65M	575.62M	596.36M	612.45M	601.43M	608.97M	614.50M	606.30M
Prepaid Assets (Quarter)	75.14M	103.80M	110.21M	110.22M	121.41M	232.20M	149.65M	103.56M	81.42M	81.76M	91.44M	82.69M	87.30M	81.60M	81.96M	80.72M	88.52M	85.30M	101.51M	98.39M
Current Assets (Quarter)	1,559.66M	1,563.47M	1,570.34M	1,520.11M	1,389.68M	1,553.60M	1,419.83M	1,411.82M	1,307.33M	1,421.79M	1,456.08M	1,377.86M	1,380.04M	1,485.48M	1,513.29M	1,587.81M	1,510.45M	1,584.69M	1,838.48M	1,911.18M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	471.17M	468.42M	459.65M	514.16M	500.91M	483.62M	470.15M	469.81M	462.61M	459.11M	451.85M	447.57M	439.81M	425.38M	431.02M	424.91M	427.23M	440.33M	434.99M	442.95M
Goodwill (Quarter)	522.76M	549.09M	566.41M	593.02M	602.89M	600.97M	599.50M	598.85M	599.16M	599.21M	598.63M	598.63M	598.55M	598.53M	598.32M	597.44M	597.50M	597.41M	595.95M	595.47M
Intangibles (Quarter)	1,262.95M	1,293.33M	1,232.73M	1,166.92M	1,209.82M	1,204.22M	1,159.01M	1,096.09M	1,055.32M	1,015.38M	982.53M	890.42M	859.27M	819.94M	780.19M	732.38M	689.14M	649.55M	587.94M	563.50M
Goodwill & Intangibles (Quarter)	1,785.71M	1,842.42M	1,799.13M	1,759.94M	1,812.71M	1,805.20M	1,758.51M	1,694.95M	1,654.47M	1,614.58M	1,581.16M	1,489.05M	1,457.82M	1,418.48M	1,378.51M	1,329.81M	1,286.63M	1,246.95M	1,183.88M	1,158.97M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	19.56M	19.22M	19.53M	20.61M	63.94M	79.84M	108.26M	103.22M	86.43M	93.24M	89.04M	55.52M	73.75M	77.03M	36.27M	60.13M	45.42M	44.85M	39.46M	57.80M
Non-Current Assets (Quarter)	2,400.41M	2,459.58M	2,404.07M	2,419.56M	2,499.29M	2,487.80M	2,454.21M	2,387.52M	2,319.28M	2,279.10M	2,231.00M	2,094.71M	2,076.35M	2,024.44M	1,947.68M	1,913.64M	1,854.80M	1,838.10M	1,761.40M	1,767.10M
Assets (Quarter)	3,960.07M	4,023.05M	3,974.41M	3,939.66M	3,888.97M	4,041.41M	3,874.04M	3,799.34M	3,626.61M	3,700.89M	3,687.08M	3,472.57M	3,456.40M	3,509.92M	3,460.98M	3,501.45M	3,365.25M	3,422.79M	3,599.87M	3,678.28M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	574.32M	596.23M	589.41M	525.35M	539.73M	561.69M	531.46M	538.20M	467.42M	0.09M	0.06M	0.00M	558.52M	0.00M		1.21M	50.90M	666.82M	0.04M	38.83M
Notes Payables (Quarter)								39.71M		40.56M	41.00M	41.45M	41.89M
Payables (Quarter)	574.32M	596.23M	589.41M	525.35M	539.73M	561.69M	531.46M	577.90M	467.42M	40.65M	41.06M	41.45M	600.41M	0.00M		1.21M	50.90M	666.82M	0.04M	38.83M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)				58.00M		275.34M	176.09M	107.48M	76.32M	77.01M	76.83M	76.99M	30.13M	30.74M	30.18M	31.75M	43.50M	41.52M	40.60M	43.26M
Short term Debt (Quarter)	20.10M	30.46M	30.47M	47.86M	30.52M	85.00M	3.87M	29.96M	29.96M	120.00M	30.53M	179.00M	179.00M	225.16M	224.69M	224.21M	31.79M	31.18M	7.20M
Current Leases (Quarter)	3.02M	8.24M	2.58M	2.64M	9.90M	10.10M	2.81M	2.87M	9.02M	9.86M	3.10M	9.21M	9.51M	3.20M	9.70M	3.21M	3.32M	8.22M	3.46M	2.71M
Current Taxes (Quarter)
Total Current Liabilities (Quarter)	636.78M	672.86M	667.34M	677.24M	602.04M	993.06M	818.00M	752.80M	703.71M	777.35M	760.60M	846.60M	834.39M	1,114.35M	1,095.21M	1,129.77M	1,075.82M	1,107.13M	862.11M	881.63M
Non-Current Liabilities
Capital Leases (Quarter)	61.87M			60.25M	60.29M	60.01M	61.31M	60.77M	60.24M	59.84M	59.35M	58.57M	58.81M	58.01M	57.56M	56.89M	56.60M	56.02M	55.67M	54.93M
Non-Current Debt (Quarter)	36.83M	2,720.12M	37.63M	38.04M	38.44M	38.86M	2,607.22M	2,591.98M	2,561.72M	2,549.18M	2,541.81M	2,386.00M	2,377.71M	2,177.58M	2,169.61M	2,161.79M	2,153.98M	2,146.40M	2,566.50M	2,565.11M
Minority Interest (Quarter)	13.08M	14.11M	15.26M	16.91M	16.42M	17.89M	22.38M	24.95M	27.53M	32.11M	37.14M	41.29M	47.02M	53.42M	59.89M	64.97M	72.61M	65.80M	67.78M	77.29M
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	22.31M	34.72M	32.56M	64.00M	18.09M	28.90M	26.37M	59.23M	30.78M	14.39M	13.60M	48.91M	26.79M	26.78M	26.21M	47.04M	8.52M	27.62M	26.41M	58.80M
Other Non-Current Liabilities (Quarter)	63.79M	63.26M	60.80M	38.90M	32.87M	79.21M	78.26M	5.93M	41.46M	6.77M	1.91M	8.14M	24.58M		26.19M		1.10M	1.75M	1.00M	19.13M
Total Non-Current Liabilities (Quarter)	2,943.50M	2,945.81M	2,908.65M	2,878.54M	2,863.10M	2,857.47M	2,839.38M	2,837.61M	2,760.70M	2,740.66M	2,735.10M	2,564.67M	2,638.62M	2,399.64M	2,399.45M	2,416.21M	2,348.81M	2,362.39M	2,779.94M	2,790.68M
Total Liabilities (Quarter)	3,593.36M	3,632.78M	3,591.24M	3,572.69M	3,481.56M	3,868.41M	3,679.75M	3,615.36M	3,491.94M	3,550.12M	3,532.84M	3,452.56M	3,520.03M	3,567.41M	3,554.55M	3,610.71M	3,497.25M	3,535.32M	3,709.83M	3,749.07M
Shareholder's Equity
Total Debt (Quarter)	56.93M	2,750.58M	68.10M	85.90M	68.97M	123.86M	2,611.08M	2,621.94M	2,591.69M	2,669.18M	2,572.35M	2,565.00M	2,556.71M	2,402.73M	2,394.30M	2,386.00M	2,185.77M	2,177.58M	2,573.70M	2,565.11M
Common Equity (Quarter)	366.71M	390.27M	383.17M	366.97M	407.41M	172.99M	194.29M	183.98M	134.67M	150.77M	154.24M	20.01M	-63.63M	-57.49M	-93.57M	-109.27M	-132.00M	-112.53M	-109.95M	-70.79M
Shareholder's Equity (Quarter)	366.71M	390.27M	383.17M	366.97M	407.41M	172.99M	194.29M	183.98M	134.67M	150.77M	154.24M	20.01M	-63.63M	-57.49M	-93.57M	-109.27M	-132.00M	-112.53M	-109.95M	-70.79M
Liabilities and Shareholders Equity (Quarter)	3,960.07M	4,023.05M	3,974.41M	3,939.66M	3,888.97M	4,041.41M	3,874.04M	3,799.34M	3,626.61M	3,700.89M	3,687.08M	3,472.57M	3,456.40M	3,509.92M	3,460.98M	3,501.45M	3,365.25M	3,422.79M	3,599.87M	3,678.28M
Retained Earnings (Quarter)	-280.12M	-33.98M	-33.23M	-24.83M	-0.35M	-399.16M	-401.85M	-406.18M	-413.13M	8.08M	3.87M	-490.18M	-581.82M	-30.44M	-575.98M	-65.51M	-594.87M	-97.43M	-105.88M	-110.73M
Treasury Shares (Quarter)								17.93M				17.45M				17.58M				15.86M

Research Tools

Amneal Pharmaceuticals Balance Sheet (2017-2025) | AMRX

Create an account

Sign In

Reset Password